prostate cancer | Medivizor | source: Medivizor | Added Jul 08, 2021
On Being a Cancer Survivor: Patient Experience of Peripheral Neuropathy
Being Informed For Vilma Aleida, neuropathy was a surprise. "Neuropathy appeared in 2011 during my 7th chemo....That 7th chemo was the infusion of two treatments (taxotere and trastuzumab). The result send me to the ER, the pain was only relieved with morphine. After that, I have been living with neuropathy
prostate cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added Jul 01, 2021
Evaluating the effectiveness of salvage radiotherapy for recurrence after prostate surgery in patients with localized prostate cancer.
This study evaluated the effectiveness of salvage radiotherapy (RT) in patients with recurrence of prostate cancer (PCa) after prostate surgery. The study found that salvage RT was effective in the management of PCa recurrence with manageable side effects.
prostate cancer | Medivizor | source: Medivizor | Added Jun 25, 2021
Increasing Awareness: What is Cachexia?
Eating Together For many, being able to commune around a table--talking, laughing and eating--is a sign of health and well-being. That's why, when someone is sick, and doesn't eat, conflict can result. Caregivers may feel enormous anxiety, guilt and hopelessness as their loved one loses weight. Yet, caregivers need toprostate cancer | Research | Treatment | 10 pages | source: European Urology | Added Jun 02, 2021
Analyzing the effectiveness and safety of Lutetium-177–labeled PSMA–targeted therapy in patients with metastatic castration-resistant prostate cancer.
This study reviewed the effectiveness and safety of lutetium-177 [177Lu]-prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (PRLT) for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC). The data showed that PRLT was associated with good outcomes and manageable side effects.
prostate cancer | Research | Lifestyle | 10 pages | source: Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer | Added Apr 30, 2021
Can physical exercise improve the quality of life of patients with prostate cancer?
This study aimed to evaluate the effectiveness of physical exercise in patients with prostate cancer. The study concluded that physical exercise is associated with reduction of tiredness, and improving functional capacity and quality of life in these patients.
prostate cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added Apr 07, 2021
Evaluating patient-reported outcomes with enzalutamide in the treatment of non-metastatic castration-resistant prostate cancer
This study evaluated patient-reported outcomes in men with non-metastatic castration-resistant prostate cancer (CRPC) when treated with either enzalutamide (Xtandi) or a placebo. The data showed that enzalutamide treatment delayed the time until pain progression and improved the quality of life of patients compared to a placebo.
prostate cancer | Research | Treatment | Guidelines | 10 pages | source: Journal of the National Comprehensive Cancer Network | Added Apr 05, 2021
Updated NCCN guidelines for the treatment of advanced prostate cancer
This study reviewed the current NCCN guidelines for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
prostate cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added Feb 27, 2021
Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer
This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity.
prostate cancer | Research | 5 pages | source: Cancer Letters | Added Feb 08, 2021
Evaluating the effects of statin therapy and cancer recurrence in prostate cancer patients treated with radiotherapy
This study evaluated whether statin use after radiation therapy in patients with prostate cancer (PCa) might have any benefits in terms of cancer recurrence (return of the cancer). The main findings were that statin use before, during and after radiotherapy did not provide any additional benefits in preventing PCa recurrence.
prostate cancer | Research | Treatment | 10 pages | source: Cochrane database of systematic reviews | Added Jan 14, 2021
Evaluating the effects of abiraterone acetate in combination with androgen deprivation therapy for the treatment of metastatic hormone-sensitive prostate cancer.
This study examined the effects of abiraterone acetate (AA; Zytiga) in combination with androgen deprivation therapy (ADT) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). The data showed that AA and ADT combination improves the outcomes in these patients.
